Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $48.6100 (-3.98%) ($48.3900 - $48.6100) on Wed. Feb. 10, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.13% (three month average) | RSI | 52 | Latest Price | $48.6100(-3.98%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA advances 0.8% a day on average for past five trading days. | Weekly Trend | IOVA advances 5% a week on average for past two weeks. | Market Behavior | Normal for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) IBB(48%) XBI(44%) ARKG(43%) IWO(42%) ARKK(39%) | Factors Impacting IOVA price | IOVA will decline at least -1.565% in a week (0% probabilities). VIXM(-23%) UUP(-16%) VXX(-12%) TBT(-6%) UNG(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.565% (StdDev 3.13%) | Hourly BBV | -2 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | 5 Day Moving Average | $50.02(-2.82%) | 10 Day Moving Average | $47.68(1.95%) | 20 Day Moving Average | $47.87(1.55%) | To recent high | -7.6% | To recent low | 34.5% | Market Cap | $7.118b | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |